SAPHNELO
Active substance: Anifrolumab
INJECTION, SOLUTION · ANIFROLUMAB 300 mg/2mL
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ANIFROLUMAB · 300 mg/2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12094-2aad-77aa-9859-cefab9447df1,01a1209d-d97a-7010-ba58-a3866d11c639;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-3040
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0310-3040 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-3040 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-3040 · Verified 2026-10-09 · open in source